Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.04B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$542M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$469M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$433M |
| 5 |
Microsoft
MSFT
|
+$300M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$749M |
| 2 |
BPL
Buckeye Partners, L.P.
BPL
|
+$447M |
| 3 |
Alibaba
BABA
|
+$274M |
| 4 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$273M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.66% |
| 2 | Financials | 5.43% |
| 3 | Healthcare | 5.11% |
| 4 | Consumer Discretionary | 4.43% |
| 5 | Communication Services | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
3976
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $782K | ﹤0.01% |
21,600
+9,600
| +80% | +$294K |
|
|
CY
3977
PUT
DELISTED
Cypress Semiconductor
CY
| $782K | ﹤0.01% |
33,500
+2,200
| +7% | +$51.5K |
|
3978
Coherus Oncology
CHRS
$222M
| $780K | ﹤0.01% |
43,299
-44,229
| -51% | -$816K |
|
3979
Cavco Industries
CVCO
$4.24B
| $777K | ﹤0.01% |
3,976
-2,364
| -37% | -$463K |
|
3980
CALL
Burlington
BURL
$23.2B
| $775K | ﹤0.01% |
3,400
+200
| +6% | +$41.8K |
|
3981
Columbus McKinnon
CMCO
$564M
| $775K | ﹤0.01% |
19,368
+11,600
| +149% | +$448K |
|
3982
PUT
Gold Fields
GFI
$30B
| $775K | ﹤0.01% |
117,400
+13,600
| +13% | +$77.1K |
|
3983
ATI
ATI
$25.8B
| $773K | ﹤0.01% |
37,439
+19,726
| +111% | +$428K |
|
3984
Schneider National
SNDR
$6.26B
| $772K | ﹤0.01% |
35,391
-3,293
| -9% | -$74.1K |
|
3985
CALL
Aon
AON
$76.2B
| $771K | ﹤0.01% |
3,700
+700
| +23% | +$139K |
|
3986
PUT
iShares MSCI Germany ETF
EWG
$1.6B
| $770K | ﹤0.01% |
26,200
-3,000
| -10% | -$85.6K |
|
|
SCS
3987
DELISTED
Steelcase
SCS
| $770K | ﹤0.01% |
37,626
-8,602
| -19% | -$159K |
|
|
ATRS
3988
DELISTED
Antares Pharma, Inc.
ATRS
| $770K | ﹤0.01% |
163,921
+143,579
| +706% | +$588K |
|
|
HEES
3989
DELISTED
H&E Equipment Services
HEES
| $769K | ﹤0.01% |
23,018
+4,469
| +24% | +$145K |
|
|
CCXI
3990
DELISTED
ChemoCentryx, Inc.
CCXI
| $769K | ﹤0.01% |
19,436
+15,880
| +447% | +$279K |
|
3991
PUT
IPG Photonics
IPGP
$3.7B
| $768K | ﹤0.01% |
5,300
-2,200
| -29% | -$306K |
|
3992
Ubiquiti
UI
$33.3B
| $768K | ﹤0.01% |
4,063
-1,634
| -29% | -$264K |
|
|
AMAG
3993
DELISTED
AMAG Pharmaceuticals
AMAG
| $768K | ﹤0.01% |
63,087
-25,175
| -29% | -$275K |
|
3994
PUT
Perrigo
PRGO
$1.46B
| $765K | ﹤0.01% |
14,800
+900
| +6% | +$47.1K |
|
|
PRNB
3995
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $763K | ﹤0.01% |
13,927
+12,783
| +1,117% | +$477K |
|
3996
CALL
American Water Works
AWK
$26.8B
| $762K | ﹤0.01% |
6,200
+2,800
| +82% | +$339K |
|
3997
CALL
Smith & Wesson
SWBI
$657M
| $762K | ﹤0.01% |
106,812
-27,061
| -20% | -$165K |
|
3998
Upwork
UPWK
$1.16B
| $762K | ﹤0.01% |
71,392
+67,148
| +1,582% | +$846K |
|
3999
Halozyme
HALO
$9.85B
| $760K | ﹤0.01% |
42,912
-10,022
| -19% | -$174K |
|
4000
CALL
Rambus
RMBS
$10B
| $759K | ﹤0.01% |
55,100
-36,300
| -40% | -$487K |
|
Similar funds
Citigroup's Q4 2019 Portfolio in Review
As of Q4 2019, Citigroup held 8,009 positions worth $138B, up 9.5% from $126B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Citigroup's Q4 2019 filing shows 285 new, 3,874 increased, 2,887 reduced and 270 closed positions. Its largest new stake was Stanley Black & Decker, Inc.: 372,155 shares worth $40.5M. The largest sale was Celgene Corp, an estimated $749M.
By sector, the portfolio is most concentrated in Technology at 6.7% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q4 2019 buy was Stanley Black & Decker, Inc.: 372,155 shares worth $40.5M.
- Citigroup added most to Invesco QQQ Trust in Q4 2019, an estimated $1.04B increase.
- Citigroup's biggest Q4 2019 reduction was Alibaba, cutting an estimated $274M.
- Citigroup fully exited Celgene Corp in Q4 2019, selling an estimated $749M.
- Citigroup's ten largest holdings make up 18% of its $138B portfolio in Q4 2019.
- Citigroup opened 285 new positions and closed 270 in Q4 2019.
- Citigroup's portfolio value rose 9.5% quarter-over-quarter to $138B.
Based on Citigroup's 13F filing for Q4 2019, filed 12 Feb 2020.